It’s a global industry and there’s a lot happening. We know it’s not always easy keeping up with everything that’s happening around the world that could impact the US dietary supplements industry. The answer? Our weekly round-up of key news from across...
Bioenergy Ribose says its recent Novel Foods approval in the EU will help stoke the considerable momentum the brand has built up over the years, a momentum that helps it win the fight against copy cat material.
In the end, the only thing the dietary supplement industry has to sell is trust. While that trust may be enough for it to weather the stress an intensified trade war may impose, it is no cause for the industry to rest on its laurels.
Despite comments made by then FDA Commissioner Scott Gottlieb to the contrary, the US Food and Drug Administration does not have a policy of enforcement discretion with respect to products derived from cannabis and its components, including cannabidiol...
Supplement company Healthycell is betting on a specialized gel format, served in single-serve sachets, to bring consumers what founder and CEO Douglas Giampapa argues is ‘maximum bioavailability’ of nutrients.
Notes from the Dietary Supplements Regulatory Summit
What do housing crises and dietary supplement recalls have in common? They cause a big bust to consumer trust, said Frank Yiannas, deputy commissioner for food policy and response at the Food and Drug Administration.
Biosciences firm Probiotics Australia has opened the country's first cGMP- and TGA-certified facility dedicated to probiotic API manufacturing, with an eye on expanding the use of probiotics in food for Chinese consumers.